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significant dephasing of protons due to 
the magnetic field inhomogeneity induced 
in the water molecules within the cells.[1] 
Magnetic NPs also provide a promising 
application in cancer therapy through mag-
netic hyperthermia, which utilizes the heat 
generated by magnetic NPs under an alter-
nating field to kill tumor cells.[1–3] Magnetic 
NPs injected into the body for diagnosis 
could also be used in subsequent therapy. 
The concept of theranostics (a combination 
of diagnosis and therapy) would be highly 
advantageous to medicine as the same 
particles can be used for detection and for 
treatment of tumors.[4] However, magnetic 
NPs serving as theranostic agents are still 
in an early stage of development.
Iron oxide nanoparticles (IONPs) have 
been considered a promising candidate for 
an MRI contrast and cancer treatment with 
hyperthermia due to their biocompatibility. 
The typical relaxivity and specific absorp-
tion rate (SAR) of iron oxide-based magnetic 
NPs range from 100 to 200 S−1 mMFe−1 and 100 to 500 W g−1, 
respectively, and still require further improvement to reduce the 
required dosage for clinical usage.[1,2] Several approaches for 
optimizing the MRI contrast of IONPs have been demonstrated 
by varying their composition (saturation magnetization),[5–9] sur-
face treatment,[8–13] or size.[5–9] As for the SAR, power dissipation 
The controlled size and surface treatment of magnetic nanoparticles 
(NPs) make one-stage combination feasible for enhanced magnetic 
resonance imaging (MRI) contrast and effective hyperthermia. However, 
superparamagnetic behavior, essential for avoiding the aggregation 
of magnetic NPs, substantially limits their performance. Here, a 
superparamagnetic core–shell structure is developed, which promotes 
the formation of vortex-like intraparticle magnetization structures in the 
remanent state, leading to reduced dipolar interactions between two 
neighboring NPs, while during an MRI scan, the presence of a DC magnetic 
field induces the formation of NP chains, introducing increased local 
inhomogeneous dipole fields that enhance relaxivity. The core–shell NPs 
also reveal an augmented anisotropy, due to exchange coupling to the high 
anisotropy core, which enhances the specific absorption rate. This in vivo 
tumor study reveals that the tumor cells can be clearly diagnosed during an 
MRI scan and the tumor size is substantially reduced through hyperthermia 
therapy by using the same FePt@iron oxide nanoparticles, realizing the 
concept of theranostics.
Magnetic Resonance Imaging
One of the current challenges in biomedical science is that of 
developing multifunctional materials with functionality for both 
ultrasensitive imaging and highly effective therapy. Magnetic 
nanoparticles (NPs) have been widely used as magnetic reso-
nance imaging (MRI) contrast agents. When an external mag-
netic field is applied, the magnetic NPs that label cells cause a 
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can be enhanced by tuning magnetic anisotropy, particle size, or 
saturation magnetization.[14,15] To extend the functionality and 
overcome the limitations of single-component magnetic NPs, 
the magnetic core can be selectively modified to compliment the 
properties of the shell. The magnetic core–shell structure, which 
possesses tunable magnetic anisotropy and magnetization, has 
been demonstrated to achieve contrast-enhanced MRI[16,17] or 
efficient heat induction.[14] However, very limited reports so far 
demonstrate superparamagnetic NPs for highly effective thera-
nostics, that is, enhanced r2 and SAR simultaneously.
Regarding MRI contrast, r2 relaxivity has been reported to 
depend on the properties of a single magnetic particle based on 
outer-sphere relaxation theory.[18] However, during the MRI pro-
cess, a strong DC magnetic field is applied to align the protons, 
and a small AC field is used to disturb their alignment, contrib-
uting to T2 relaxation due to local variations in precession rate. 
Therefore, magnetic NPs may interact with each other in the 
presence of magnetic fields and form various forms of clusters 
or assemblies. So far, no related investigations have addressed 
how magnetic interactions between NPs influence the forma-
tion of clusters or assemblies under magnetic fields. Likewise, 
the effect on T2-weighted MRI has not yet been discussed.
Here, we demonstrate the importance of the magnetic inter-
action between NPs for both the relaxivity and the SAR, which 
provides a new tuning knob for NP designs used for MRI and 
hyperthermia. By using core–shell superparamagnetic NPs 
composed of FePt core protected by a biocompatible cubic 
Fe3O4 shell, we can tune magnetic interactions among NPs as 
well as between the core and shell. The monodispersed FePt@
IONPs are shown to simultaneously possess highly effective T2-
shorting (r2 = 360 mM
−1 s−1) and high-efficiency hyperthermia 
(SAR = 1.21 kW g−1), which enables therapy immediately after a 
diagnosis using the same NPs.
Cubic FePt@IONPs show a high r2 relaxivity of 360 mM
−1 s−1 
at 4.7 T, while the r2 relaxivity of cubic IONPs and Resovist 
are lower, at 129 and 194 mM−1 s−1 (Figure 1a). The FePt@
IONP nanocubes also show significantly darkened phantom 
images, as shown in Figure 1b, which correspond to a strongly 
enhanced T2 contrast relative to the cubic IONPs and Resovist 
NPs. Resovist and our cubic IONPs show SAR values of 0.39 
and 0.92 kW g−1, respectively, while FePt@IONPs exhibits a 
value of 1.21 kW g−1 (Figure 1c). (See Section S1, Supporting 
Information, for details of the SAR calculations of NPs.) For 
the cancer hyperthermia treatment, the temperature needs to 
be increased to 42 °C. Because of the high SAR, the required 
dose and exposure time to reach 42 °C in the in vitro experi-
ment are only 0.1 mg mL−1 of FePt@IONPs and 100 s, respec-
tively, measured with an AC magnetic field of 18.8 kA m−1 at 
630 kHz and with dispersion volume of 0.2 mL. For the in vivo 
theranostic demonstrations presented here, MRI was acquired 
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Figure 1. a–c) The relaxivity and hyperthermia measurement of NPs. a) The variation of 1/T2 with Fe concentration of cubic FePt@IONPs (red triangle 
line), Resovist (green square line), and cubic IONPs (blue circle line) measured at 4.7 T. The r2 relaxivities (mM
−1 s−1) were obtained from fitting the 
slope of each sample. b) T2-weighted images of Resovist, cubic IONPs, and cubic FePt@IONPs with the same Fe concentration, measured at 4.7 T. 
c) Measurement of heat generation of the NPs, carried out by using an AC magnetic field produced from radiofrequency heating machine. The rate 
of the temperature increase was 0.29, 0.22, and 0.04 °C s−1 for FePt@IONP, IONP and Resovist, respectively. d) In vivo thernanostic performance of 
NPs, schematic picture shows real-time MRI-controlled magnetic hyperthermia system for tumor treatment, e) T2*-weighted MR images of KB tumor 
of a mouse with Resovist (left) and FePt@IONP (right). f) Plot of tumor volume ratio (tumor volume/initial tumor volume) versus days after treatment 
with FePt@IONP hyperthermia, Resovist hyperthermia, untreated control, and FePt@IONP control.
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with a quadrature surface coil using a spin echo sequence with 
DC magnetic field, and magnetic hyperthermia was applied 
with an AC magnetic field provided by a magnetic induction 
local coil with a diameter of 3 cm[19] (Figure 1d). Theranostic 
application of core–shell FePt@IONPs was carried out in KB 
human cervical cancer cells xenografted mice model. FePt@
IONPs were intravenously injected into mice at 0.1 mg mL−1 
with the dispersion volume of 0.2 mL; 24 h later, the mice 
were placed in a 3 T MRI head coil and subsequently under 
the magnetic induction local coil for magnetic hyperthermia. 
The tumor MR contrast ability of FePt@IONP is about 
1.5 times higher than that of Resovist (Figure 1e). Note that 
the different mice may exhibit different background MR sig-
nals in tumor areas. In our tumor MR contrast, we compare 
the contrast in tumor area with background in the same mice 
so that we can do fair comparison for MRI contrast with dif-
ferent contrast agents.[20] We also compare MR images taken 
at kidney and liver before and after intravenous injection of 
FePt@IONPs, shown in Figure S1 (Supporting Information). 
We can clearly observe the enhanced contrast after the injec-
tion of FePt@IONP. For magnetic hyperthermia, the tumor 
area was treated with an AC magnetic field of 18.8 kA m−1 
at 630 kHz for 10 min and the tumor size was monitored 
for up to half a month. Significant delay of tumor growth 
was observed in FePt@IONP hyperthermia group at day 
15 whereas Resovist hyperthermia group revealed no inhibition 
of tumor growth compared with untreated control group (nei-
ther NPs nor hyperthermia treatment) (Figure 1f). Note that 
the tumor volume still increases for the FePt@IONP control 
sample (with FePt@IONP but without hyperthermia), which 
clearly indicates that FePt@IONPs show efficient magnetic 
hyperthermia treatment of the cancer due to their high SAR. 
Furthermore, the increased tumor volume in the FePt@IONP 
control sample also suggests that cytotoxicity of FePt@IONP is 
not severe. Clear MRI images of NPs can accurately locate the 
tumor region where the same NPs can be used for highly effec-
tive hyperthermia to realize the theranostic modality of precise 
diagnosis and treatment.
To extend the functionality and overcome the limitations 
of single-component magnetic NPs, the magnetic core can be 
selectively modified to compliment the properties of the shell. 
Figure 2a shows the transmission electron microscopy (TEM) 
image of Fe3O4 nanocubes. The average edge length of Fe3O4 
cubes is 16.1 ± 0.9 nm and that of the bi-magnetic core–shell 
FePt@IONPs with FePt core and cubic shell Fe3O4 is 
14.7 ± 1.1 nm (Figure 2b). The disordered FePt NPs are spher-
ical, exhibiting superparamagnetic behavior due to their small 
size of about 4.1 nm. The high-quality single-crystalline struc-
ture of the nanocubes is shown in Figure 2c. The FePt core 
obviously embedded inside the cubes was demonstrated by 
aligning a tilt series in 3D TEM tomography (Figure 2c). The 
X-ray diffraction (XRD) patterns of the nanocube assembly on 
Si substrates indicate that our IONP structure corresponds to 
the Fe3O4 lattice (Figure S2a–c, Supporting Information). The 
X-ray photoelectron spectra (XPS) of IONPs and FePt@IONPs 
also show no satellite peak between the peaks of Fe 2p3/2 and 
Fe 2p1/2, indicating that these nanocubes are consistent with 
the Fe3O4 component (Figure S2e,f, Supporting Information).
Adv. Mater. 2018, 1802444
Figure 2. Structural and microstructural analyses of IONPs and FePt@IONPs. a) TEM image of cubic IONPs. b) TEM image of cubic FePt@IONPs. 
c) (Left) The core–shell NPs with FePt core and Fe3O4 cubic shell are further demonstrated by the HRTEM images (the dashed circle indicates the 
position of FePt core). (Middle) The lattice fringes correspond to {220} lattice planes of IONPs while the facet is {100}. (Right) 3D TEM tomography 
of the FePt@IONPs core–shell structure.
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Before discussing the mechanism of superior performance 
of the FePt@INOPs in both MRI contrast and hyperthermia, 
we first evaluated the cytotoxicity and stability of FePt@INOPs 
dispersed in water. To demonstrate the effects of magnetic inter-
action of NPs on MRI contrast, we specifically used a surfactant 
with short-chain molecules, CTAB (hexadecylcetyltrimethyl-
ammonium bromide, FW: 364.45), a well-known surfactant for 
dispersing and stabilization of NPs. On the other hand, CTAB-
stabilized NPs used for bioapplications may cast doubts about 
their cytotoxicity. Therefore, we also used mPEG (methoxy-
polyethylene glycol, FW: 350) as a surfactant. The mPEG-
coated IONP is widely used for bioapplication and reveals no 
cytotoxicity.[21] The selected mPEG possesses similar molecular 
weight to CTAB and its short-chain molecule does not signifi-
cantly change the hydrodynamic diameter, therefore, mPEG-
coated NPs may provide the similar magnetic interactions 
among NPs to CTAB-coated NPs. The enhancements of r2 and 
SAR by using mPEG-coated FePt@IONPs (Figure S3, Sup-
porting Information) are similar to those shown in Figure 1, 
by using CTAB-coated FePt@IONPs. Figures S4 and S5 
(Supporting Information) show 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay for KB cells and 
hematoxylin and eosin (H&E) staining of major organs after 
the magnetic hyperthermia treatment, respectively. Both results 
clearly demonstrate that mPEG-coated FePt@IONPs have no 
toxic reaction for KB cells and organs. In addition, dynamic 
light scattering (DLS) data reveal that the particle size for mono-
disperse FePt@IONP and IONP does not change significantly 
after 24 h (Figure S6, Supporting Information), indicating no 
aggregation occurs. All results clearly demonstrate that our 
FePt@IONP can be directly applied to MRI and hyperthermia 
without concerns of cytotoxicity and stability.
The hysteresis loops for nanocubes in water (Figure 3a) 
reveal that both cubic IONPs and FePt@IONPs exhibit super-
paramagnetic behavior at room temperature. The theoretical 
saturation magnetizations of bulk Fe3O4 and FePt are 471 and 
1140 emu cc−1, respectively. The FePt core does not contribute 
significantly to the magnetic moment as it accounts for merely 
1% of the volume of the magnetic structure. When the proton 
diffusion length is not negligible with respect to the size of NPs, 
the MRI relaxivity can be described in the motional averaging 
regime of protons. The relaxivity is expected to be directly pro-
portional to the NP size squared and to the saturation magnetiza-
tion.[22,23] Also, the SAR value is expected to be linearly dependent 
on the saturation magnetization for superparamagnetic NPs.[1] 
Since our cubic IONPs and FePt@IONPs have similar sizes and 
saturation magnetization, the enhanced contrast and heating 
efficiency of FePt@IONPs in comparison to IONPs cannot be 
attributed to these two factors. A slight increase of coercivity 
for FePt@IONPs at a low temperature can be attributed to the 
interaction between the magnetically soft IONP shell and rela-
tively hard FePt core (Figure S7, Supporting Information). In 
addition, hysteresis loops show that the initial susceptibility 
of cubic IONPs is higher than that of FePt@IONPs. The fre-
quency-dependent susceptibilities (Figure 3b) also reveal higher 
susceptibility for IONPs. It should be noted that the IONPs show 
a broader peak of the imaginary part of the susceptibility com-
pared to FePt@IONPs. The fits of the susceptibility for polydis-
perse model of IONPs and monodisperse model of FePt@IONPs 
are presented in Figure S8 (Supporting Information),[24–27] which 
indicate that the magnetic interaction between IONPs in solution 
is stronger than that between FePt@IONPs.
Adv. Mater. 2018, 1802444
Figure 3. Magnetic properties and magnetic structural scattering of NPs. 
a) Magnetic hysteresis loops of FePt@IONPs and IONPs dispersed in 
water with the concentration of 1 mgFe mL−1. b) The real and imaginary 
parts of magnetic susceptibility frequency spectra of FePt@IONPs 
and IONPs dispersed in water with the concentration of 1 mgFe mL−1. 
c) Small-angle neutron scattering fitted by the Porod network scattering 
and magnetic clusters model. Solvated cubic IONPs (blue circle line) 
reveal long-range magnetic scattering that is absent in cubic FePt@IONPs 
(red triangle line).
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To further quantify the particle interaction of structur-
ally uniform magnetite NPs,[28,29] we performed small-angle 
neutron scattering (SANS) at the NIST Center for Neutron 
Research on beam lines NG3 and NG7. The nanocubic IONPs 
and FePt@IONPs were measured in a D2O solution at the con-
centration of 5 mg mL−1. The neutron scattering from D2O is 
similar to that of Fe3O4, thereby largely masking the structural 
scattering of the Fe3O4 while retaining its full magnetic scat-
tering intensity. The cubic FePt@IONPs exhibit a Q−2.5 Porod 
slope, as shown in Figure 3c, consistent with the presence of 
surfactant with a slope between that of mass fractal and surface 
fractal scattering.[28,29] The cubic IONPs display the same Porod 
slope plus the addition of a shoulder which can be fitted using 
a cluster model of size 88 nm (or roughly 5–6 nanocubes). 
Given that the cubic FePt@IONPs exhibit no structural scat-
tering features associated with the nanocube shape, the IONP 
cluster scattering appears to be magnetic in origin. The SANS 
data indicate that the IONPs tend to cluster together, while the 
FePt@IONPs nanocubes pack less tightly and do not exhibit 
aggregation when solvated. Consequently, the IONPs form 
interparticle magnetic domains, while the magnetic domains 
of FePt@IONP nanocubes are limited in size to a single NP 
and exhibit no apparent magnetic coupling. Solvated IONPs 
consistently exhibit magnetic correlations, while FePt@IONPs 
do not. According to the SANS results, the primary function of 
the FePt is to disrupt the formation of the long-range magnetic 
dipolar interaction at zero field thereby reducing clustering in 
FePt@IONP.
Furthermore, using electron holography to observe interfer-
ence fringe patterns allows a phase shift of the high-energy 
electron wave transmitted through the specimen to be meas-
ured by high-resolution TEM.[30–32] The electron holography of 
magnetic structures for FePt@IONPs and IONPs in dried sam-
ples demonstrates the natural magnetic vector fields within and 
between the particles, as shown in Figure 4a,b. The observed 
flux-closure domain of FePt@IONPs prevents the NPs from 
interacting with each other. The domain structure of nanocubes 
was simulated by using micromagnetic calculations (OOMMF 
code),[32] as shown in Figure S9 (Supporting Information). 
The magnetic induction flux lines in the two IONPs present 
an induction state characteristic of interacting nanocubes, but 
the flux closure state exhibited by the FePt@IONPs indicates a 
magnetic vortex configuration. The flux closure state of FePt@
IONPs may explain a diversity of observations, including the 
suppressed long-range magnetic dipolar interaction in solution, 
susceptibility measurements, and small-angle neutron scat-
tering. The suppressed magnetic interaction in FePt@IONPs 
also helps prevent NP aggregation and cluster formation, con-
sistent with our in vivo observation that mice survival rate is 
increased with FePt@IONPs due to the reduced detrimental 
effects on blood circulation.
During the MRI measurements, a strong magnetic DC field 
and a small orthogonal AC pulse field are applied, which may 
alter the NP configuration. To understand how the magnetic 
field influences the formation of magnetic clusters or assem-
blies, we deposited a solution containing NPs on a TEM grid. 
During the drying process, we applied magnetic fields. When 
a DC field of 0.47 T was applied, the IONPs yield bundles of 
IONP chains aligned with the DC field direction (Figure 4c). 
The long chains are broken down into separate small clusters 
by simultaneously applying an orthogonal AC pulse field of 
0.5 mT at 20 MHz and a DC field of 0.47 T. The separated clus-
ters are still aligned with the DC field (Figure 4d). On the other 
hand, the magnetically aligned FePt@IONP chains under a 
DC field (Figure 4e) are essentially unchanged by simultane-
ously applying AC pulse fields (Figure 4f). The evolutions of 
chains of IONPs and FePt@IONPs dispersed in water with a 
concentration of 0.5 × 10−3 M under DC and pulse AC fields 
applied were recorded in situ using an optical microscope and 
are shown in Movies S1 and S2 (Supporting Information). The 
recording clearly demonstrates that the FePt cores seem to 
be strongly aligned by the DC field so that the FePt@IONPs 
chains cannot be dissociated with pulse AC fields. The effects 
of DC field on the assembly of IONPs and FePt@IONPs are 
also shown in Figure S10 (Supporting Information). When 
fields are off, both IONPs and FePt@IONPs chains are well 
dispersed again in the solution (Figure S10, Supporting Infor-
mation). Furthermore, the AC susceptibility spectra for both 
NPs in solution are unchanged after removing magnetic fields, 
which confirms the reversible assembly process from monodis-
persed NP (no field) to chains (in DC field) (Figure S11, Sup-
porting Information).
To understand how the interaction between NPs affects 
relaxation rate R2 (R2 = 1/T2) in MRI measurement, we per-
formed a Monte Carlo simulation as described in refs.[19,20] and 
the Experimental Section. To compare experiments, we investi-
gated the role of the local configuration by simulating the MRI 
of discontinuous chains for the IONP sample and continuous 
chains for the FePt@IONP sample. Each discontinuous or con-
tinuous (6 × 2 × 2) chain contains 24 particles. In addition, for 
comparison, we considered the case of single randomly dis-
tributed particles. For each type of configuration, the system 
was constructed using ≈1500 magnetic NPs. The relaxation 
rate as a function of concentration (packing density) for each 
configuration type is illustrated in Figure 5a. The r2 relaxivity 
of the FePt@IONPs continuous chain is about 2.15 times 
higher than flocculated clusters of IONPs, which compares 
well to the experimental observation of 2.8 times (Figure 1a). 
The relaxation curves for the large structures (as experimentally 
illustrated in Figure 4) were also calculated to examine the role 
of the NP configurations at this scale (Figure S12, Supporting 
Information).
The simulation corroborates the experimental data, showing 
the influence of spatial configuration on magnetic particle prop-
erties. Importantly, it is demonstrated that the performance of 
magnetic NPs in MRI does not depend just on macroscopic 
properties such as packing density (average concentration), but 
also on microscopic properties (local concentration or local con-
figuration/arrangement). The R2 depends on the dipole field 
acting on each proton. This is nonuniform and strongly influ-
enced by the geometry/position of the magnetic NPs as illus-
trated in Figure 5b,c. Here, we show the dipole map of a section 
of the sample, which indicates the location and configuration of 
NPs. The dipole field map varies locally throughout the sample. 
This is supported by the dipole field histogram computed over 
the entire sample (Figure 5d), which highlights the influence 
of the NP configuration in enhancing the spatial distribution 
of dipolar fields. This has an important effect on the MRI 
Adv. Mater. 2018, 1802444
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performance as the diffusing protons will experience different 
dipolar fields depending on the spatial location. If we analyze 
the tail of the dipole field distribution (related to large field and 
therefore fast dephasing, Figure 5e) we can see that there is a 
direct correlation of the distribution tail with the R2 values. The 
NP chain has a systematically larger volume with a stronger 
dipole field compared to the discontinuous chains (discrete 
flocculated clusters). This corresponds to a faster dephasing of 
the protons and therefore an enhancement of the MRI perfor-
mance (i.e., a larger R2). As all the systems investigated here are 
identical, with the exception of the spatial configuration, we can 
conclude that the details of NP configuration have an important 
role to play in determining the MRI performance.
With the understanding of magnetic interaction effects 
on the relaxation and MRI contrast, we would like to further 
illustrate the uniqueness of our core–shell structures. The 
presence of superparamagnetic FePt core plays an impor-
tant role on the magnetic interaction among NPs. At zero 
field, the existence of a FePt core leads to the formation of 
closure domains within FePt@IONPs, which disrupts the for-
mation of the long-range dipolar interaction. The energy cost 
of forming a vortex is the exchange energy associated with a 
point divergence of the magnetization at the center. Applying 
a field stabilizes the magnetization of FePt and makes the 
vortex structure less energetically feasible, leading to the 
observed chain formation in an applied field. The reduced 
Adv. Mater. 2018, 1802444
Figure 4. Electron holography and TEM analyses of NPs. a,b) Magnetic induction maps recorded using off-axis electron holography at the remanent
state for cubic FePt@IONPs (a) and cubic IONPs (b) (the white dotted lines are added to indicate the location of NPs). c–f) TEM images, and the 
inset in (d) shows a large-scale image, for NPs with a Fe concentration of 0.5 × 10−3 M. c) IONPs under a DC magnetic field of 0.47 T and d) IONPs 
under the DC magnetic field of 0.47 T and an orthogonal AC field of 0.5 mT at 20 MHz. e) FePt@IONPs under a DC magnetic field of 0.47 T and f) 
FePt@IONPs under a DC magnetic field of 0.47 T and an orthogonal AC field of 0.5 mT at 20 MHz.
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Figure 5. R2 results from Monte Carlo simulation. a) The dependence of R2 on the packing density for two configurations of NPs: the continuous chains 
(red triangle) and the aligned discrete clusters (discontinuous chain: blue circle). For reference we also consider the case where the NPs are separated 
(single particle: open circle). b,c) Color maps of the dipole field in systems of discontinuous chains (X–Z plane) (b) and continuous chains (6 × 2 × 2) 
(c). The number of particle per cluster for discontinuous chains is 6 in the 3D structure. d) Statistics of the dipole field amplitude for continuous and 
discontinuous chains. e) Statistics of volume percentage with field larger than a given value. This corresponds to the tail of the dipole field distribution 
in the sample volume, which is responsible for the fast dephasing. The continuous chain has a larger field overall, leading to a larger R2.
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dipolar interaction in zero field helps the circulation of NPs 
in the bloodstream and enhances SAR. On the other hand, 
under a strong DC field, the FePt core is strongly aligned by 
the DC field such that the NPs chains are not disturbed by 
the applied AC pulse field. The chain configuration formed 
by magnetic fields reveals a stronger dipolar field around the 
chain, which corresponds to a faster dephasing of the proton 
and therefore an enhancement of the MRI performance. We 
would like to emphasize that our approach can be combined 
with other methods to further increase relaxivity. For example, 
by increasing the particle size (17.8 nm) of superparamag-
netic core–shell structure, we can further improve the relax-
ivity to 411.3 mM−1 s−1, as shown in Figure S13 (Supporting 
Information). Our approach shows great potential to reach 
even higher r2 by further optimization. Thus, highly effective 
multifunctional NPs for bioapplications can be successfully 
realized by designing core–shell structures to tune magnetic 
interactions among NPs.
For hyperthermia treatment, cubic NPs have been reported 
to have a higher SAR than spherical ones due to increased ani-
sotropy.[33] The magnetic core–shell structure with exchange 
coupling between a magnetically hard core and soft shell can 
further enhance anisotropy and thus the SAR.[14] In addition 
to anisotropy, the simulations reveal that reduced magnetic 
dipolar interaction among NPs can raise the SAR.[34] Both 
susceptibility spectra (Figure 3b) and small-angle neutron 
scattering spectra (Figure 3c) show that the FePt@IONP sus-
pension have greatly reduced magnetic dipolar interactions 
between NPs in zero field compared to IONPs, which may also 
contribute to the enhanced SAR.
In summary, we demonstrate that superparamagnetic 
cube FePt@IONPs core–shell NPs are suitable to be used as 
theranostic agents because of their higher relaxivity and SAR 
value. We reveal that the magnetic NP interaction not only 
influences the T2-weighted image but also the SAR. The FePt 
core is essential for forming the specific flux-closure domain 
in the core–shell structure. The cubic FePt@IONP core–shell 
has several prominent advantages. First, the magnetic core–
shell structure, with lower magnetic dipole–dipole interactions 
among the particles, can be designed to stabilize magnetic 
NPs against aggregation caused by magnetic interactions in 
the remanent state. Second, the FePt core may be exchange-
coupled to the IONP shell, which significantly enhances the 
SAR. Furthermore, the presence of the FePt core maintains 
chain-like assemblies during AC field pulses in MRI measure-
ment, which essentially enhances R2. With the ability to tune 
magnetic interactions between NPs, the design of multi-
functional cubic FePt@IONP can be devoted to improving the 
resolution of the MRI image and effective hyperthermia for 
theranostic applications.
Experimental Section
Synthesis of FePt Cores: Synthesis of FePt NPs was carried out by 
using standard Schlenk line techniques under Ar atmosphere. In a 
typical synthesis process, Pt(acac)3 (0.25 mmol), Fe(CO)5 (0.75 mmol), 
1,2-hexadecanediol (2 mmol), oleic acid (1.2 mmol), and oleylamine 
(1.2 mmol) were mixed and dissolved in benzyl ether (10 mL). The 
mixed solution was heated to 290 °C with a heating rate of 5 °C min−1. 
The temperature was kept at 290 °C for 30 min. Then the solution was 
naturally cooled to room temperature. The NPs were washed by ethanol 
and redispersed in hexane several times. The final product was stored 
in hexane.
Synthesis of Cubic Fe3O4 and FePt@IONP: The details of synthesis 
of cubic Fe3O4 can be found in ref. [35] and the similar approach was 
used for the synthesis of the shell of FePt@IONPs. The synthesis of 
the shaped FePt@IONP core/shell nanocubes involved two steps, 
including the synthesis of a FePt core and the overgrowth of a shaped 
Fe3O4 shell. The prepared FePt NPs were mixed with oleic acid 
(0.3 mmol), oleylamine (0.3 mmol), and 1,2-tetradecanediol (5 mmol) 
and were dissolved in benzyl ether (15 mL) which served as the reaction 
solution. For the precursor solution, Fe(acac)3 (1 mmol) was dissolved 
in benzyl ether (5 mL). The reaction solution was dewatered at 120 °C 
for 1 h and was then heated to the reflux temperature of 290 °C. Then, 
the precursor solution was injected into the hot reaction solution 
at 290 °C with an injection rate of 10 mL h−1. The fluctuation of the 
reaction temperature was less than 5 °C during the injection process. 
After the reaction was finished, the NPs were washed in ethanol and 
redispersed in hexane. Both Fe3O4 NPs and FePt@IONP were modified 
with short-chain surfactants (such as CTAB or mPEG) to be dispersed 
in water.
Synthesis of CTAB-FePt@IONP: The core–shell FePt@IONPs were 
then dried under vacuum and added into an aqueous solution containing 
0.1 M CTAB (FW: 364.45). After 10 min sonication, the core–shell FePt@
IONP NPs were coated by CTAB and formed stable NP dispersion in 
water.
Synthesis of mPEG-FePt@IONP: The dopamine-based surfactant 
to replace oleylamine around the iron oxide nanoparticles as reported 
in ref. [36] was used. To functionalize the FePt@IONP nanoparticles 
with mPEG, trichloro-s-triazine (TsT) (22 mg) was first used to react 
with mPEG (average mol wt: 350) (200 mg) at room temperature in 
anhydrous benzene (20 mL) to form TsT-mPEG. Then, TsT-mPEG 
(20 mg) reacts with dopamine hydrochloride (20 mg) in 1,4-dioxane 
solvent, forming compound. The catecol unit in dopamine-based 
molecule was used to replace oleylamine around the iron oxide NPs, 
forming stable NP dispersions in water.
Supporting Information
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from the author.
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